ETON

Eton Pharmaceuticals (ETON)

About Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Details

Daily high

$7.48

Daily low

$6.37

Price at open

$7.24

52 Week High

$7.66

52 Week Low

$3.03

Market cap

191.2M

Dividend yield

0.00%

Volume

372,460

Avg. volume

203,084

P/E ratio

-28.51

Eton Pharmaceuticals News